Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor
- PMID: 19837905
- DOI: 10.1124/mol.109.060251
Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor
Abstract
Seven-transmembrane G protein-coupled receptors (GPCRs) represent the single largest family of cell surface receptors. Signaling through these receptors is controlled by changes in the conformation of the receptor from inactive to active conformations, which in turn lead to the activation of multiple downstream signaling pathways. To facilitate greater diversity in signaling responses, many of these receptors are capable of adopting several distinct active conformations, in which each couples preferentially to its own set of downstream signaling partners. Because these unique signaling responses result from specific receptor active conformations, GPCR signaling may be directed toward these selective responses through either strength-of-signal effects resulting from partial agonism or through biased agonism and functional selectivity, resulting from the selective stabilization of one active conformation over the others. This review uses the CB(1) cannabinoid receptor as a specific example to highlight the contribution of two important aspects of GPCR function-orthosteric ligand binding and receptor heterodimerization-toward directed GPCR signaling.
Similar articles
-
Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.Pharmacol Ther. 2004 Jul;103(1):21-80. doi: 10.1016/j.pharmthera.2004.05.002. Pharmacol Ther. 2004. PMID: 15251227 Review.
-
Cannabinoid receptor homo- and heterodimerization.Life Sci. 2005 Aug 19;77(14):1667-73. doi: 10.1016/j.lfs.2005.05.011. Life Sci. 2005. PMID: 15978631 Review.
-
Dimerization in GPCR mobility and signaling.Curr Opin Pharmacol. 2010 Feb;10(1):53-8. doi: 10.1016/j.coph.2009.10.007. Epub 2009 Nov 10. Curr Opin Pharmacol. 2010. PMID: 19910252 Review.
-
Conformational complexity of G-protein-coupled receptors.Trends Pharmacol Sci. 2007 Aug;28(8):397-406. doi: 10.1016/j.tips.2007.06.003. Epub 2007 Jul 13. Trends Pharmacol Sci. 2007. PMID: 17629961 Review.
-
What's for lunch at the conformational cafeteria?Mol Pharmacol. 2005 Jun;67(6):1819-21. doi: 10.1124/mol.105.013060. Epub 2005 Mar 22. Mol Pharmacol. 2005. PMID: 15784844 Review.
Cited by
-
Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A.J Biol Chem. 2011 Oct 28;286(43):37414-28. doi: 10.1074/jbc.M111.287649. Epub 2011 Sep 9. J Biol Chem. 2011. PMID: 21908614 Free PMC article.
-
N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways.Mol Pharmacol. 2013 Jan;83(1):267-82. doi: 10.1124/mol.112.081182. Epub 2012 Oct 25. Mol Pharmacol. 2013. PMID: 23104136 Free PMC article.
-
Cannabis and Cannabinoid Signaling: Research Gaps and Opportunities.J Pharmacol Exp Ther. 2024 Oct 18;391(2):154-158. doi: 10.1124/jpet.124.002331. J Pharmacol Exp Ther. 2024. PMID: 39060161 Free PMC article. Review.
-
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies.Nat Rev Neurosci. 2014 Dec;15(12):786-801. doi: 10.1038/nrn3846. Nat Rev Neurosci. 2014. PMID: 25409697 Free PMC article. Review.
-
Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain.Medchemcomm. 2019 Mar 18;10(5):647-659. doi: 10.1039/c8md00595h. eCollection 2019 May 1. Medchemcomm. 2019. PMID: 31191856 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
